Cresset Asset Management, LLC Guardant Health, Inc. Transaction History

Cresset Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$109.77 - $165.68 $189,682 - $286,295	-1,728 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$127.04 - $179.1 $8,511 - $11,999	67 Added 4.03%	1,728 $264,000
Q4 2020 Feb 11, 2021	BUY	$99.96 - $135.93 $166,033 - $225,779	1,661 New	1,661 $214,000
Q2 2019 Aug 12, 2019	SELL	$63.94 - $91.11 $12,851 - $18,313	-201 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$34.3 - $97.98 $6,894 - $19,693	201 New	201 $15,000

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.34B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cresset Asset Management, LLC with notifications on news.